Article

Warburg Pincus acquires B&L

Warburg Pincus has completed its acquisition of Bausch & Lomb (B&L) for a total purchase price of approximately $4.5 billion, including nearly $830 million of debt.

Rochester, NY-Warburg Pincus has completed its acquisition of Bausch & Lomb (B&L) for a total purchase price of approximately $4.5 billion, including nearly $830 million of debt.

"With a strong and supportive partner in Warburg Pincus, we are well positioned to create new opportunities for Bausch & Lomb and advance our leadership in the eye health industry," said Ronald L. Zarrella, chairman and chief executive officer of B&L.

Elizabeth H. Weatherman, a Warburg Pincus managing director, said, "We're delighted to be partners with B&L. We look forward to helping the company build upon its rich heritage and premier brand in ophthalmology."

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.